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1. Introduction 
It is known that the Down syndrome phenotype can result from a triplication of a small 
portion of chromosome 21. In the majority of cases diagnosed as Down syndrome (90%), 
free trisomy for chromosome 21 is found; in some 6% of the cases translocations are 
observed, and about 3% are mosaics with normal cell line; other aberrations involving 
chromosome 21 are rare and found in less than 1% [Mikkelsen, 1988]. In a huge literature on 
the epidemiology of Down syndrome, there are two features undoubtedly established, a 
strong association of free trisomy 21 frequency with advanced maternal age, and male 
prevalence among patients with Down syndrome due to regular trisomy 21. 
Generally, the clinical diagnosis is straightforward and well-known to all medical workers 
[Mikkelsen, 1988]. However, misdiagnosis (false positive diagnosis) of Down syndrome was 
reported in numerous publications [Ahmed et al., 2005; Baccichetti et al., 1990; Ballesta et al., 
1977; Engel et al., 1970; Fried et al., 1980; Hamerton et al., 1965; Melve et al., 2008; Szollar et 
al., 1983], being particularly high in neonates [Devlin & Morrison, 2004; Hindley & 
Medakkar, 2002]. Factors which alter suspicion of trisomy 21 are known to be early delivery 
and prematurity [Mikkelsen, 1988].  
Previous studies reported a significant female prevalence among Down syndrome patients 
with clinical diagnosis only which suggested that gender also may alter a suspicion of Down 
syndrome in infants [Kovaleva et al., 1999; Kovaleva, 2002]. Therefore, the main objectives of 
this study were to evaluate a rate of false positive diagnosis of Down syndrome in a large 
well-defined geographically population and to determine male-to-female ratio (sex ratio, 
SR) among patients with false-positive diagnosis. 
2. Materials and methods 
St. Petersburg is a large city with a population of about 5 million, and an average of 50 000 
births a year. Almost all births take place in a hospital. There is one major clinical genetic 
unit in the city which provides the service to the target population, the St. Petersburg Centre 
for Medical Genetics. The overwhelming majority of live born babies suspected to have 
genetic disease have been examined by clinical geneticists from the Centre within the first 
several days after birth and prior to discharge from a hospital. Medical personnel at children 
hospitals and special institutions for handicapped children may also call for a clinical 
www.intechopen.com
  
Prenatal Diagnosis and Screening for Down Syndrome 
 
204 
geneticist for suspected genetic condition. It is mandated that few cases born in private 
hospitals and tested cytogenetically elsewhere, must be reported to the Centre. Older 
patients or their parents can arrange an appointment to the Centre themselves after being 
referred to by medical specialists. Only certified clinical geneticists at St. Petersburg Centre 
for Medical Genetics can request karyotyping to confirm or refute a suspected chromosomal 
abnormality. 
In St. Petersburg, due to global social transition, the birth rate fell dramatically from about 
73 thousand in 1987 to 29 thousand in 1999 which caused a decline in the number of live 
born patients with Down syndrome over time. Since 2000, the birth rate begun to increase 
steadily, reaching more than 50 thousand in 2009. However, at the same time, since 2000, the 
impact of prenatal diagnosis on the prevalence of Down syndrome prevalence has been 
expanding rapidly, affecting the number of live born babies with Down syndrome.  
The completeness of cytogenetic confirmation of trisomy 21 varied significantly, increasing 
from 21% in 1970 to almost 100% currently. Therefore, for the sake of sufficient sample size, 
the author has chosen for the analysis the period of 1986-2009, when data completeness had 
begun improving from 82% in 1986 to about 100% in 1999 and upward. 
All cases of Down syndrome delivered during the period January 1, 1986 to December 31, 
2009 were abstracted from a population-based registry, the St. Petersburg Down Syndrome 
Register, founded and run by the author. The Register has been collecting data on all Down 
syndrome patients residing in St. Petersburg, whether diagnosed antenatally or live born 
since 1970. The method for data collection has been described elsewhere [Kovaleva et al., 
2001]. 
Data on patients suspected to have Down syndrome but with a normal karyotype were 
retrieved from logbooks of the cytogenetic laboratory at the St. Petersburg Centre for 
Medical Genetics and from logbooks of the cytogenetic laboratory at the Leningrad Oblast 
Children Hospital which provides service to the regions surrounding St. Petersburg. The 
degree of certainty of the Down syndrome diagnosis was determined by presence of 
question mark(s) in the records of indication for karyotyping in the logbooks. When the 
diagnosis at clinical examination seemed obvious, the question mark was absent. In 
doubtful cases, sometimes up to three question marks presented in the record. In some 
cases, suspected mosaicism was an indication. The data obtained were analyzed using 
standard statistics including binomial test and Chi-square test with Yates correction. 
3. Results 
Over a period of twenty-four years (from 1.01.1986 to 31.12.2009), 1257 children had been 
referred to cytogenetic investigation for either confirmation or exclusion of trisomy 21. The 
Down syndrome diagnosis was confirmed in 1129 (89.8%) of them and 120 (9.5%) children 
had a normal karyotype. The remaining eight children with another chromosomal 
abnormality were excluded from the analysis (Table 1). 1119 cases of trisomy 21 were 
diagnosed in the St. Petersburg Centre for Medical Genetics and ten cases were diagnosed 
elsewhere. The sex ratio among children with confirmed DS diagnosis was skewed, with a 
surplus of males (612 males/517 females, SR=1.18). In contrast, among children with a 
normal karyotype, there was a strong female prevalence (25 males/95 females, SR=0.26), the 
difference is highly significant, p << 0.0001. 
Neonates constituted 94% of patients with confirmed Down syndrome while a proportion of 
neonates among those with false positive diagnosis was appreciably smaller (65%). 
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Therefore a proportion of false positive cases among neonates was 6.8% compared to 35% in 
patients aged one month and older (Table 1). The annual rate of false positives among 
neonates varied from 0% in 1990, 1995, and in 2000 to 21% in 2008 (Figure 1). There was an 
apparent trend with an increase in false positives in relation to a reduction in the number of 
cases tested. This variation did not depend on the clinical experience of the referring 
doctors. For example, 8 of 9 false positive cases in 2008 were referred to cytogenetic testing 
by clinical geneticists whose experience had exceeded 15 years, and the remaining one case 
was suspected to have Down syndrome by a clinical geneticist with 7 years of experience.  
 
Age of patients 
True Down 
syndrome 
(trisomy 21) 
False positive diagnosis 
Total 
Normal 
karyotype 
Other 
chromosomal 
abnormality 
Neonates 1063 77 6 a 1146 
Patients under 1 yo 59 20 2b 81 
Patients aged 1 yo 
and older 
7 23  30 
Total 1129 120 8 1257 
a 46,XY,18p-; 46,XX,t(11;22); 46,X,t(X;16)(p11;q13); 46,XX,r(18); 46,XX, r(18); 47,XXX 
b 46,XY,add(10)(q26); 46,XX,inv(22)(p13;q12) 
Table 1. Proportion of false positive diagnosis according to the patients' age at cytogenetic 
examination 
Among false positive neonates, there was a very strong female prevalence, with 11 males/ 
66 females, SR=0.17. Notable female predominance was also found in both patients aged 
under 1 year old (7 males/13 females, SR=0.54) and in older patients (7 males/16 females, 
SR=0.44).  
Further analysis was performed regardless of the date and place of birth of the patients. 
Overall, a normal karyotype was diagnosed in 103 neonates (17 males/86 females, SR = 0.20, 
different from population value of 1.06, p < 0.0001), in 68 children of the age group up to 1 
year old (24M/44 females, SR = 0.55, p = 0.0052), and in 64 children aged 1 year and older 
(29M/35 females, SR = 0.83, p > 0.05).  
Data on the level of certainty in false positives cases is presented in Table 2. The diagnosis at 
clinical examination seemed obvious in 22% of neonates and in only 6% of children 1 year 
and older. In two cases, since features of Down syndrome were obvious, chromosome 
testing was requested twice. The proportion of suggested mosaicism was increased with the 
patients’ age, from 3% in neonates to about 10% in the oldest group of patients. Request for 
excluding Down syndrome was noted in two cases only. Unquestionable Down syndrome 
diagnosis was stated in 20% and mosaicism was suspected in about 9% of males, while in 
females these figures were 14% and 4% correspondingly (Table 3). 
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Fig. 1. Total number of cytogenetically tested cases (red line) and proportion of cases with 
false positive diagnosis (blue line).  
 
Expression of certainty 
Patients with false positive diagnosis of Down syndrome 
Neonates Under 1 yo 1 yo and older Total 
Down syndrome  22 (22%) 11 (16%) 4 (6%) 37 
Mosaicism? 3 (3%) 3 (4.5%) 6 (9.5%) 12 
Down syndrome?  60 (58%) 51 (75%) 53 (83%) 164 
Down syndrome?? 14 (14%) 2 (3%) 1 (1.5%) 17 
Down syndrome??? 2 (2%) 1 (1.5%)  3 
Request for excluding 
Down syndrome  
2 (2%)   2 
Total 103 68 64 235 
Table 2. Degree of certainty in requesting for cytogenetic testing according to the age of the 
patients 
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Expression of certainty 
Patients with false positive diagnosis of Down 
syndrome 
Males Females Total 
Down syndrome 14 (20%) 23 (14%) 37 
Mosaicism? 6 (8.5%) 6 (4%) 12 
Down syndrome? 47 (67%) 117 (71%) 164 
Down syndrome?? 2 (3%) 15 (4%) 17 
Down syndrome??? 1 (1.5%) 2 (1%) 3 
Request for excluding Down 
syndrome 
0 2 (1%) 2 
Total 70 165 235 
Table 3. Degree of certainty in requesting for cytogenetic testing according to the gender of 
patients with false positive diagnosis 
Data on distribution of both true Down syndrome patients and false positives by maternal 
age is presented in Table 4. The analysis of maternal age distribution in false positive 
patients was complicated since maternal ages were available in only a small proportion of 
the sample. There is some increase (13%) in the proportion of mothers aged 35 years old and 
older compared to general population (6% to 9%), due to a higher proportion (23.5%) of 
mothers of advantaged ages in the group of patients 1 year old and older. The overall figure 
of 13% in false positives is significantly lower compared to about 33% in true Down 
syndrome (p = 0.0003).  
 
Maternal 
age 
Down 
syndrome 
Patients with false positive diagnosis of Down syndrome 
Neonates Under 1 yo 
1 yo and 
older 
Total 
< 20 87  6  3  1  10  
20-24 378  6  7  5  18  
25-29 367  15  3  5  23  
30-34 324  10  4  2  16  
35-39 352 
33% 
2 
7.5% 
2 
15% 
3 
23.5% 
7 
13% 
40+ 213 1 1 1 3 
Total 1721  40  20  17  77  
Table 4. Maternal ages in Down syndrome and in false positive diagnosis, 1970-2009 
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4. Discussion 
4.1 Proportion of false positive cases 
Over the study period, 1129 postnatal cases of Down syndrome were identified. Regular 
trisomy 21 was observed in 90.9%, translocation trisomy in 5.4%, and mosaicism in 3.7% of 
the cases. These figures are in accordance with previous data worldwide. One hundred-
twenty cases, referred for cytogenetic examination for suspicion of Down syndrome, 
displayed a normal karyotype, while eight children were diagnosed with another 
chromosome abnormality. Therefore, the proportion of misdiagnosed cases was 10.2% 
(128/1129). Analysis of the literature (Table 5) showed these data to be in agreement with 
majority of previous studies. Data from Spain [Ballesta et al., 1997] is of particular interest 
regarding the object of the present publication. The authors performed rigorous clinical 
screening of patients with suspected Down syndrome followed by cytogenetic testing. 
Eleven of 71 (15.5%) patients with psychomotor delay and features of Down syndrome were 
found to have a normal karyotype. On subsequent fluorescent in situ hybridization (FISH) 
testing, only one of them had triplication of the Down syndrome region on FISH testing. 
When neonates were analyzed separately, the false positive rate has improved up to 7.2%. 
Among publications where data on accuracy of Down syndrome diagnosis can be found 
there are some reporting on the prevalence of false positive diagnosis in neonates [Devlin & 
Morrison, 2004; Fried, 1980; Hall, 1964; Hindley & Medakkar, 2002; Melve et al., 2008; 
Sivakumar & Larkins, 2004]. The rate of false positives in our sample appeared to be the 
lowest, being closer to figure of 9.6% in Norway [Melve et al., 2008]. Annual rate of false 
positive diagnosis varied significantly, from 0% in 1990, 1995, and in 2000 to 21% (9 of 42) in 
2001 (Figure 1). Obviously this variation did not depend on the clinical experience of the 
referring doctors. Similar figures were reported by Melve et al. [2008], the highest annual 
number of false positives in neonates was 18 (18.9%) and the lowest was 4 (4.8%). 
False positive diagnosis implies a great undue mental stress for parents, therefore maximizing 
clinical diagnostic accuracy is of importance [Hindley & Medakkar, 2002]. Significance of 
expert clinical assessment of a patient before cytogenetic testing was explored by Sivakumar & 
Larkins [2004]. They reported a more favorable accuracy rate from Birmingham Women’s 
Hospital (25 of 29 suspected cases had trisomy 21) compared to the West Midland region (false 
positive rate 14% and 36%, correspondingly). “This can be explained by the fact that the 
tertiary hospital may have more experienced neonatologists compared to the broad cohort of 
junior and senior pediatricians… We believe that an assessment by a senior pediatrician before 
testing may minimize the risk of negative results.”[Sivakumar & Larkins, 2004]. The data from 
the present study, that is a low false positive rate as the result of expert clinical assessment by 
clinical geneticists, support this suggestion. 
4.2 Degree of certainty about the diagnosis of Down syndrome 
4.2.1 Degree of certainty about the diagnosis of Down syndrome in false positive 
cases 
Despite the widely held belief that the clinical diagnosis of Down syndrome is very obvious, 
some publications report on difficulties of clinical judgment arising in the neonatal period 
[Druce et al., 1995; Fried, 1980; Hall, 1966; Hindley & Medakkar, 2002; Lee et al., 1961]. 
Factors which alter suspicion of Down syndrome are known to be early delivery and 
prematurity [Mikkelsen, 1988]. No data on sex difference in suspicion of Down syndrome or 
in degree of certainty of DS diagnosis were reported before. 
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Source Country 
Study 
period 
Age of patients 
Number 
of tested 
patients 
Proportion of 
false positive 
diagnosis 
Hamerton 
et al, 1965 
UK 1960-1964 not specified 173 16 (9%) 
Engel 
et al., 1970 
Germany 1963-1968 various ages 365 6 (15%) 
Johnson 
et al., 1985 
Ohio, USA 1970-1981 various ages 769 a 48 (6%) 
New York, 
USA 
1980-1983 various ages 126 b 10 (8%) c 
Szollar 
et al., 1983 
Hungary 1970-1979 
under 1 yo 214 16 (7.5%) 
1 yo and older 85 3 (3.5%) 
Czeizel, 
1988 
Hungary 1973-1982 various ages 81 4 (5%) 
Baccichetti 
et al., 1990 
Italy 1988 
teenagers and 
adults 
predominantly 
116 14 (12%) 
Ballesta 
et al., 1997 
Spain 
not 
specified 
not neonates 71 11 (15.5%) d 
Ahmed 
et al., 2005 
Pakistan 1998-2001 various ages 325 30 (9%) e 
a,b  cytogenetic confirmation in about 77% of the patients;  c  including one case with trisomy 18; d  FISH 
study of 11 cases detected a partial trisomy 21 in one case;  e including 12 cases with other chromosomal 
anomalies 
Table 5. Accuracy of the clinical diagnosis of Down syndrome in patients of various ages 
Data presented in Table 2 suggests that the level of certainty in false positives cases was 
comparably low, decreasing with the patients’ age. The diagnosis at clinical examination 
seemed obvious in 22% of neonates and in only 6% of children 1 year and older.  However a 
proportion of clinical diagnosis suggestive of mosaicism increased with the patients’ age, 
from 3% in neonates to about 10% in the oldest group of patients. Surprisingly, despite a 
strong prevalence of females among false positive children, a higher level of certainty of 
Down syndrome diagnosis was given to male patients (Table 3). In males, unquestionable 
Down syndrome or suspected mosaicism were indications for cytogenetic testing in 20% 
and in 8.5 %of the cases, while in females these figures were 14% and 4% respectively.  
4.2.2 Degree of certainty about the diagnosis of Down syndrome in confirmed cases 
The data reported above prompted the author to taking a quick look at degree of certainty of 
the clinical diagnosis in the cases of true Down syndrome.  It was found that 17 of 106 (16%) 
neonates with Down syndrome born during 2007-2009 had a questionable clinical diagnosis 
(including one diagnose accompanied with three question marks), among them there were 8 
males and 9 females. Thus, at least in neonates with Down syndrome, there was no 
association of clinical suspicion of the diagnosis with the gender of the patient. 
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Source 
Geographic 
area 
Study period 
Number of 
tested patients 
Proportion of 
false positive 
diagnosis 
Hall, 1964 Sweden 1961-1962 43 5 (11.6%) 
Fried, 1980 Israel 1973-1977 30 4 (13.3%) 
Hidley, & Medakkar, 
2002 
UK 1999-2000 962 307 (32%) a 
Devlin & Morrison, 
2004 
Northern 
Ireland 
1969-2001 268 d 82 (31%) b 
Sivakumar & Larkins, 
2004 
UK 2000-2002 233 85 (36%) 
Melve et al., 2008 Norway 2001-2005 376 36 (9.6%) 
Present study Russia 1986-2009 1146 83 (7.2%) c 
a including one case with 49,XXXXY; b including 5 females with another chromosomal abnormality; c 
including 2 males and 6 females with another chromosomal abnormality;  a neonates constitute 90% of 
the patients 
Table 6. Accuracy of the clinical diagnosis of Down syndrome in neonates 
4.3 Sex ratio in Down syndrome 
4.3.1 Sex ratio in cases considered or proved to be true Down syndrome 
Sex ratio in true Down syndrome is well known to be skewed towards males [Mikkelsen, 
1988; Mutton et al., 1996]. Meta-analysis of publications reporting cytogenetic profile of 
Down syndrome worldwide [Kovaleva, 2002] showed typical male prevalence (SR ~1.3) 
among both patients with regular trisomy 21 and carriers of translocation trisomy 21, either 
sporadic or inherited. The only exception is mosaic variant of trisomy, where some 
prevalence of females was documented (SR~0.96).  
Several hypotheses have been put forward to explain the skewed sex ratio in Down 
syndrome. Meiotic disturbance (non-homologous co-orientation in male meiosis) [Kovaleva, 
1992; Petersen et al. 1993], fertilization event (greater accessibility of Y-bearing sperm to ova 
disomic for chromosome 21 or promotion of non-disjunction in the ova by Y-bearing sperm) 
[Ferguson-Smith & Yates, 1984; Kovaleva & Mutton, 2005], and post-fertilization events 
(intrauterine selection against females) [Huether et al., 1996; Hook et al., 1999] have been 
discussed. Data from recent studies supports suggestion that male excess among live born 
with non mosaic trisomy 21 might be due to selection against female fetuses [Oliver et al., 
2009; Kovaleva, 2010]. Female prevalence among carriers of mosaic trisomy was suggested 
to be a result of sex-specific chromosome loss in early embryogenesis [Kovaleva, 2005]. 
The trigger of the present study was an observation of an intriguing dynamics of sex ratio in 
Down syndrome in St. Petersburg (former Leningrad) within period of 1970-1996 [Kovaleva 
et al., 1999] subsequently confirmed by the meta analysis of the literature [Kovaleva, 2002]. 
It was a steady increase in sex ratio from a population figure of 1.05 or even less in the 
earliest studies in 1940’s to 1.3 - 1.6 in the studies conducted during late 1980’s (Figure 2). 
Analysis showed that this increase was accounted for by the growing use of karyotyping to 
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confirm the diagnosis. Among individuals with a clinical diagnosis only, sex ratio was 0.97 
(1160 males/1198 females) [Collman & Stoller, 1962; Davidenkova et al., 1965; Huether, 
1990; Kovaleva et al., 2001; Staples et al., 1991]  while among individuals with confirmed 
trisomy 21 this figure was 1.31 (1918 males/1466 females) [Huether, 1990; Kovaleva et al., 
2001; Mikkelsen et al., 1976; Mikkelsen et al., 1990; Sharav, 1991; Staples et al., 1991; Stoll et 
al., 1990; Wahrman & Fried, 1970]. Correspondingly, in samples where proportion of clinical 
diagnosis only was 30% and more, intermediate figure of 1.12 (1950 males/1742 females) 
[Baird & Sadovnik, 1987; Christoderescu et al., 1977; Johnson et al., 1996; Kallen et al., 1996; 
Kovaleva et al., 2001; Staples et al., 1991] was observed. These observations raised a 
suggestion that low sex ratio in Down syndrome patients with clinical diagnosis only might 
be accounted by a large proportion of false positive diagnosis in females [Kovaleva, 2002]. 
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Fig. 2. Sex ratio in Down syndrome, data from epidemiological studies worldwide (adapted 
from Kovaleva [2002]). Red line: clinical diagnosis only; black line: clinical diagnosis or 
trisomy 21, green line: trisomy 21 
4.3.2 Sex ratio in false positive diagnosis  
Though theoretically, misdiagnosis should occur uniformly in both sexes, data from the 
present study demonstrates a significant female prevalence among false positive patients. In 
neonates, a five-fold prevalence of females over males was detected (17 males/86 females, 
SR = 0.20, different from population value of 1.06, p < 0.0001). Female excess diminished 
with older children; two-fold prevalence was found among children of the age up to 1 year 
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old (24 males/44 females, SR = 0.55, p = 0.0052), and notable but statistically insignificant 
prevalence among patients aged 1 year and older (29 males/35 females, SR = 0.83, p > 0.05). 
Therefore, data from the present study supports the suggestion of low sex ratio in Down 
syndrome patients with clinical diagnosis only as the result of a large proportion of false 
positive diagnosis in females. However the reason of female predominance among the 
clinically suspected Down syndrome remains unclear.  
Patients with clinical features of Down syndrome but without trisomy 21 were reported 
occasionally before the advent of molecular technologies allowing definite detection of 
Down syndrome critical region located at chromosome 21 [Hall, 1961; Hamerton & Polani, 
1962; Bowen et al., 1974]. As an explanation for absence of trisomy 21 in different tissues 
of patients with apparent manifestations of the syndrome, several suggestions were 
proposed: (1) low-level mosaicism, (2) the presence of the trisomic cell line in tissues other 
than those investigated, (3) elimination of the aberrant cell line in vivo or selective regress 
in vitro [Engel et al., 1970], and (4) gene mutation that might cause a “phenocopy” [Hall, 
1962]. 
Subsequent studies showed the presence of a cryptic duplication of the Down syndrome 
critical region in individuals with clinical diagnosis of Down syndrome and an apparently 
normal karyotype [see for reference Forster-Gibson et al., 2001]. However several patients 
with mental retardation and Down syndrome phenotype, but without molecularly 
detectable duplication of the critical region, have been reported [McCormick et al., 1989; 
Ahlbom et al., 1996]. The majority of them were females. For example, a woman with 
clinically typical Down syndrome but apparently normal chromosomes, was extensively 
examined for the presence of any partial trisomy for any segment of chromosome 21. Since 
the proposita’s parents were half-sibs, and her sister suffered from the same disorder as the 
proposita, the authors suggested an autosomal recessive disorder which is phenotypically 
indistinguishable from Down syndrome [Ahlbom et al., 1996]. As it was mentioned above, 
FISH testing of 11 patients with developmental delay and clinically obvious Down 
syndrome revealed only one of them who had triplication of the critical Down syndrome 
region. Unfortunately the gender of the patients was not reported [Ballesta et al., 1997]. 
The data obtained in the present study suggest that gender in particularly significantly 
affects clinical suspicion of Down syndrome in neonates. Since characteristic features 
allowing suspicion of Down syndrome include facial dysmorphisms, one may hypothesize 
sex differences in the normal process of facial cranium ontogenesis during perinatal period.  
In patients aged one year and older, sex ratio (0.83) appeared to be close to sex ratio typical 
to carriers of mosaic trisomy 21 (0.96). In this group, proportion of mothers of advanced age 
seemed to be increased which might support a suggestion of undetected mosaicism in some 
of these patients. An abnormal condition(s) specific to females might also be implicated in a 
proportion of the misdiagnosed cases.  
4.4 Implications of false positive-female-prevalence-phenomenon to Down syndrome 
epidemiology 
The observation of female prevalence in false positive clinically diagnosed cases allows an 
insight into the ground for reported sex ratio variability in Down syndrome. For example, 
the ECLAM (Estudio Colaborativo Latinoamericano de Malformaciones Congenitas) group 
reported as “an unusual finding” a markedly low sex ratio (0.98) found in 3,157 newborn 
Down syndrome patients in South America populations [Carothers et al., 2001]. Only 13% of 
the patients were reported to have confirmed diagnosis, therefore, in the light of the data 
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presented in this paper, a low sex ratio among patients mostly clinically diagnosed as Down 
syndrome, is a well expected finding.  
Moreover, based on data on sex ratio in both all clinically diagnosed cases and true Down 
syndrome cases in a population where sufficient completeness of cytogenetic confirmation is 
not readily achievable, it is realizable to calculate a crude rate of false positives [Kovaleva, 
2002]. For example, assuming all males among clinically diagnosed cases in ECLAM’s 
sample to be true Down syndrome (which can not be absolutely correct since some false 
positive cases might be found among males) and typical for Down syndrome sex ratio to be 
1.3, for 1563 males, 1203 females (not 1594) are expected, with odd number of 391 females. 
Resulted proportion of misdiagnosed cases is 391/3,157=12%. 
The results from the present study might have some further implications. (1) Overestimation 
of maternal age-specific rates due to false positive cases, in young women predominantly, 
might take place in the early years of monitoring of Down syndrome, as well as in 
populations with a high proportion of unconfirmed cases (those covered by Chernobyl 
fallout in the Former Soviet Republics). (2) It was generally accepted that maternal age 
specific risks were stable over time, and variations in population rates were explained by 
changing in maternal age composition [Huether et al., 1998; Carothers et al., 2001]. However 
if age-specific rates stay stable over long time, irrespective of increase in proportion of 
confirmed cases, it might indicate an increase in real rates. (3) The results from this study 
would suggest that the use of epidemiological data collected on Down syndrome prior to 
routine cytogenetic analysis, should be reconsidered in meta-analyses of Down syndrome 
population data. 
5. Conclusion  
The present study is the largest study to address the accuracy of clinical diagnosis of Down 
syndrome and the first one demonstrating that gender may affect a clinical suspicion of a 
chromosomal disease. The advantages of this study are well-defined geographical 
population, clinical screening of the cases suspected to have a chromosomal disease by 
experienced clinical geneticists prior to requesting for cytogenetic testing, a high 
completeness of cytogenetic confirmation of the Down syndrome diagnosis, and perfect 
recording of the cases on logbooks of the cytogenetic laboratory at the St. Petersburg Centre 
for Medical Genetics. Apparent limitations of this study are a lack of detailed clinical 
description of the cases and absence of follow-up. Additional studies, both clinical and 
genetic, would be reasonable for uncovering mechanism(s) responsible for the remarkable 
sex bias in clinical suspicion of Down syndrome.  
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